316 related articles for article (PubMed ID: 30773067)
1. Recent advances in the metabolomic study of bladder cancer.
Amara CS; Vantaku V; Lotan Y; Putluri N
Expert Rev Proteomics; 2019 Apr; 16(4):315-324. PubMed ID: 30773067
[TBL] [Abstract][Full Text] [Related]
2. Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.
Vantaku V; Donepudi SR; Piyarathna DWB; Amara CS; Ambati CR; Tang W; Putluri V; Chandrashekar DS; Varambally S; Terris MK; Davies K; Ambs S; Bollag R; Apolo AB; Sreekumar A; Putluri N
Cancer; 2019 Mar; 125(6):921-932. PubMed ID: 30602056
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities:
Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M
Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424
[TBL] [Abstract][Full Text] [Related]
4. Integrated Analysis of the Fecal Metagenome and Metabolome in Bladder Cancer in a Chinese Population.
Qin C; Chen Z; Cao R; Shi M; Tian Y
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360204
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of the bladder cancer marker, BLCA-4.
Van Le TS; Myers J; Konety BR; Barder T; Getzenberg RH
Clin Cancer Res; 2004 Feb; 10(4):1384-91. PubMed ID: 14977841
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems.
Rodrigues D; Jerónimo C; Henrique R; Belo L; de Lourdes Bastos M; de Pinho PG; Carvalho M
Int J Cancer; 2016 Jul; 139(2):256-68. PubMed ID: 26804544
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer.
Konety BR; Nguyen TS; Brenes G; Sholder A; Lewis N; Bastacky S; Potter DM; Getzenberg RH
J Urol; 2000 Sep; 164(3 Pt 1):634-9. PubMed ID: 10953114
[TBL] [Abstract][Full Text] [Related]
8. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
Peng J; Chen YT; Chen CL; Li L
Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.
Vantaku V; Putluri V; Bader DA; Maity S; Ma J; Arnold JM; Rajapakshe K; Donepudi SR; von Rundstedt FC; Devarakonda V; Dubrulle J; Karanam B; McGuire SE; Stossi F; Jain AK; Coarfa C; Cao Q; Sikora AG; Villanueva H; Kavuri SM; Lotan Y; Sreekumar A; Putluri N
Oncogene; 2020 Oct; 39(40):6265-6285. PubMed ID: 31383940
[TBL] [Abstract][Full Text] [Related]
10. Bladder cancer biomarker screening based on non-targeted urine metabolomics.
Li J; Cheng B; Xie H; Zhan C; Li S; Bai P
Int Urol Nephrol; 2022 Jan; 54(1):23-29. PubMed ID: 34850327
[TBL] [Abstract][Full Text] [Related]
11. Bladder cancer biomarker discovery using global metabolomic profiling of urine.
Wittmann BM; Stirdivant SM; Mitchell MW; Wulff JE; McDunn JE; Li Z; Dennis-Barrie A; Neri BP; Milburn MV; Lotan Y; Wolfert RL
PLoS One; 2014; 9(12):e115870. PubMed ID: 25541698
[TBL] [Abstract][Full Text] [Related]
12. Discovering biomarkers in bladder cancer by metabolomics.
Zhang WT; Zhang ZW; Guo YD; Wang LS; Mao SY; Zhang JF; Liu MN; Yao XD
Biomark Med; 2018 Dec; 12(12):1347-1359. PubMed ID: 30507300
[TBL] [Abstract][Full Text] [Related]
13. Bladder Cancer-Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection.
Wang ZY; Li HY; Wang H; Chi Q; Liu Y; Li XM
Dis Markers; 2018; 2018():5609395. PubMed ID: 30275913
[TBL] [Abstract][Full Text] [Related]
14. BLCA-4 and UBC combined detection for early diagnosis of bladder cancer.
Cui L; Sun MM; Zhao ZH; Yang JP; Zheng YP; He LL; Chen KS; Fan QX
J Biol Regul Homeost Agents; 2016; 30(2):485-90. PubMed ID: 27358136
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic analysis of the role of BLCA-4 in bladder cancer pathobiology.
Myers-Irvin JM; Van Le TS; Getzenberg RH
Cancer Res; 2005 Aug; 65(16):7145-50. PubMed ID: 16103064
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Serological and Urological Levels of Bladder Cancer-Specific Antigen-1 (BLCA-1) in Bladder Cancer.
Wang Z; Li H; Chi Q; Qiu Y; Li X; Xin L
Med Sci Monit; 2018 Jun; 24():3882-3887. PubMed ID: 29883442
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and LINE-1 reactivation in bladder cancer are epigenetically linked through active chromatin formation.
Whongsiri P; Pimratana C; Wijitsettakul U; Sanpavat A; Jindatip D; Hoffmann MJ; Goering W; Schulz WA; Boonla C
Free Radic Biol Med; 2019 Apr; 134():419-428. PubMed ID: 30703483
[TBL] [Abstract][Full Text] [Related]
18. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N
J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
Liu X; Cheng X; Liu X; He L; Zhang W; Wang Y; Sun W; Ji Z
Int J Cancer; 2018 Jul; 143(2):408-418. PubMed ID: 29451296
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
